Biltmore Family Office LLC Has $2.51 Million Stake in Aflac Incorporated (NYSE:AFL)

Biltmore Family Office LLC reduced its holdings in Aflac Incorporated (NYSE:AFL) by 2.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,263 shares of the financial services provider’s stock after selling 500 shares during the quarter. Biltmore Family Office LLC’s holdings in Aflac were worth $2,510,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Private Trust Co. NA boosted its holdings in Aflac by 1.3% in the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after purchasing an additional 99 shares during the period. Phillips Wealth Planners LLC lifted its stake in shares of Aflac by 1.5% in the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after buying an additional 100 shares during the period. Raleigh Capital Management Inc. lifted its stake in shares of Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after buying an additional 100 shares during the period. TKG Advisors LLC grew its position in Aflac by 0.5% during the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after buying an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC increased its stake in Aflac by 1.6% during the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock valued at $720,000 after acquiring an additional 107 shares during the period. 67.44% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

AFL has been the topic of several recent research reports. Barclays decreased their price objective on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. Keefe, Bruyette & Woods decreased their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. Evercore ISI dropped their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. BMO Capital Markets began coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price on the stock. Finally, Morgan Stanley raised their price target on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $104.29.

Insiders Place Their Bets

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

Aflac Price Performance

AFL opened at $112.32 on Thursday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The company’s 50 day simple moving average is $106.87 and its 200-day simple moving average is $107.74. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The stock has a market capitalization of $61.31 billion, a P/E ratio of 11.70, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.